| 2922.41.00 | 90 | Other | kg | | | |
| 2922.42.50 | 00 | Other | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2922.43.50 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P) 0.2￠/kg + 3.1% (SG) | 15.4￠/kg + 50% |
| 2922.49 | | Other: | | | | |
| 2922.49.26 | 00 | Other: | | | | |
| 2922.49.30 | 00 | Other: | | | | |
| 2922.49.37 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 0.2￠/kg + 3.1% (SG) | 15.4￠/kg + 50% |
| 2922.49.40 | | Other: | | | | |
| 2922.49.40 | 50 | Other | kg | | | |
| 2922.49.60 | 00 | Other: | | | | |
| 2922.49.80 | 00 | Other | kg | 3.7% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 2922.50 | | Amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function: | | | | |
| 2922.50.13 | 00 | Other: | | | | |
| 2922.50.14 | 00 | Other: | | | | |
| 2922.50.17 | 00 | Dermatological agents and local anesthetics | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 51.5% |
| 2922.50.25 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 82% |
| 2922.50.35 | 00 | Other: | | | | |
| 2922.50.40 | 00 | Other | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 0.2￠/kg + 3.1% (SG) | 15.4￠/kg + 50% |
| 2922.50.50 | 00 | Other | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 30.5% |
| 2923 | | Quaternary ammonium salts and hydroxides; lecithins and other phosphoaminolipids, whether or not chemically defined: | | | | |
| 2923.20 | | Lecithins and other phosphoaminolipids: | | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2923.20.20 | 00 | Other | kg | 5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 33.4% |
| 2923.90.00 | 00 | Other | kg | 6.2% | Free (A,AU,BH,CA, CL,E,IL,J,JO, K,MA,MX, P,SG) | 15.4￠/kg + 36% |
| 2924.11.00 | 00 | Acyclic amides (including acyclic carbamates) and their derivatives; salts thereof: | | | | |
